Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
| Website | https://www.asherbio.com/ |
| Employees | 27 (27 on RocketReach) |
| Founded | 2019 |
| Phone | +65 04166789 |
| Industry | Biotechnology, Biotechnology Research, Science and Engineering, Pharmaceuticals, Therapeutics, Health Care |
| Keywords | Immunotherapy, Cancer Therapies, Targeted Therapies, Biotechnology, Drug Development, Pharmaceutical Research, Oncology, Therapeutic Antibodies, Biologics, Clinical Trials, Drug Discovery, Cell Therapy, Cancer Research, Immuno-Oncology, Biopharma, Life Sciences, Health Technology, Therapeutic Proteins |
| Competitors | Amgen, Novartis, Gilead Sciences, AbbVie, Vertex Pharmaceuticals, Genentech, Biogen, Regeneron, Shire, Lilly India +44 more (view full list) |
Looking for a particular Asher Bio employee's phone or email?
Craig Gibbs is the CEO of Asher Bio.
27 people are employed at Asher Bio.
Asher Bio is based in South San Francisco, California.